The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,950.00
Bid: 1,950.00
Ask: 1,951.00
Change: -9.00 (-0.46%)
Spread: 1.00 (0.051%)
Open: 1,942.00
High: 1,951.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises ITV And Sky To Outperform

Tue, 13th Jan 2015 09:56

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Mondays
----------
FTSE 100
----------
BERNSTEIN RAISES ITV TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 250 (220) PENCE
----------
BERNSTEIN RAISES SKY TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 1050 (900) PENCE
----------
S&P CAPITAL IQ CUTS SHIRE TO 'BUY' ('STRONG BUY') - TARGET 5350 (4700) PENCE
----------
UBS RAISES BURBERRY PRICE TARGET TO 1650 (1510) PENCE - 'NEUTRAL'
----------
Investec Lifts BAE Systems Price Target to 440P From 430P, Keeps Sell
----------
Investec Raises Meggitt Price Target To 560P From 540P, Keeps At Buy
----------
UBS RAISES MEGGITT PRICE TARGET TO 510 (490) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES GKN PRICE TARGET TO 410 (380) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES TESCO PRICE TARGET TO 185 (145) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP CUTS CENTRICA PRICE TARGET TO 275 (330) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 285 (280) PENCE - 'BUY'
----------
JEFFERIES INITIATES TULLOW OIL WITH 'UNDERPERFORM' - TARGET 345 PENCE
----------
BARCLAYS REINITIATES LONDON STOCK EXCHANGE LSE WITH 'OVERWEIGHT'
----------
BARCLAYS PUTS LONDON STOCK EXCHANGE LSE AUF 2550 PENCE
----------
CREDIT SUISSE RAISES ANTOFAGASTA TO 'NEUTRAL' ('UNDERPERFORM')
----------
BARCLAYS RAISES TAYLOR WIMPEY PRICE TARGET TO 147,6 (142,6) P - 'OVERWEIGHT'
----------
BERNSTEIN CUTS CENTRICA PRICE TARGET TO 270 (290) PENCE - 'MARKET-PERFORM'
----------
BERNSTEIN RAISES SEVERN TRENT TO 'OUTPERFORM' ('MARKET-PERFORM') - TP 2250 (1910) PENCE
----------
BERNSTEIN RAISES UNITED UTILITIES PRICE TARGET TO 1010 (980) P - 'OUTPERFORM'
----------
BERNSTEIN RAISES NATIONAL GRID PRICE TARGET TO 1010 (960) PENCE - 'OUTPERFORM'
----------
BERNSTEIN RAISES SSE PRICE TARGET TO 1450 (1330) PENCE - 'UNDERPERFORM'
----------
Liberum Raises Reed Elsevier Price Target To 1,300P, Rates At Buy
----------
Cantor Fitzgerald Raises WM Morrison Price Target To 200P, Keeps Buy
----------
JEFFERIES RAISES IAG PRICE TARGET TO 570 (480) PENCE - 'BUY'
----------
JEFFERIES RAISES EASYJET PRICE TARGET TO 1850 (1750) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN RAISES LAIRD PRICE TARGET TO 363 (318) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS RESTAURANT GROUP PRICE TARGET TO 730 (745) PENCE - 'OVERWEIGHT'
----------
SHORE CAPITAL INITIATES MAN GROUP WITH 'BUY'
----------
GOLDMAN RAISES MAN GROUP PRICE TARGET TO 185 (125) PENCE - 'NEUTRAL'
----------
SHORE CAPITAL INITIATES HENDERSON GROUP PLC WITH 'BUY'
----------
SHORE CAPITAL INITIATES JUPITER FUND WITH 'SELL'
----------
DAVY CUTS CENTAMIN PRICE TARGET TO 74 (77) PENCE - 'OUTPERFORM'
----------
NUMIS CUTS AVEVA GROUP PRICE TARGET TO 1740 (1810) PENCE - 'BUY'
----------
UBS RAISES TATE & LYLE TO 'BUY' ('NEUTRAL') - PRICE TARGET 680 (615) PENCE
----------
UBS RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 2700 (2200) PENCE - 'BUY'
----------
UBS CUTS AFREN PRICE TARGET TO 32 (55) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES CABLE & WIRELESS PRICE TARGET TO 70 (68) PENCE - 'BUY'
----------
GOLDMAN RAISES TALK TALK TELECOM PRICE TARGET TO 474,40 (419) PENCE - 'NEUTRAL'
----------
LIBERUM CUTS COBHAM TO 'HOLD' ('BUY') - TARGET 330 PENCE
----------
CREDIT SUISSE CUTS KAZ MINERALS TO 'UNDERPERFORM' ('NEUTRAL')
----------
BARCLAYS CUTS GREENE KING PRICE TARGET TO 835 (900) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HOMESERVE PRICE TARGET TO 223 (211) PENCE - 'UNDERWEIGHT'
----------
TRADERS: NUMIS CUTS CINEWORLD TO 'HOLD' ('ADD') - TARGET 420 PENCE
----------
BERNSTEIN RAISES DRAX TO 'OUTPERFORM' ('UNDERPERFORM') - TARGET 420 (550) PENCE
----------
Cantor Fitzgerald Raises Debenhams Price Target To 70P, Keeps At Hold
----------
Investec Cuts Debenhams To Sell From Hold, Price Target 66p
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS LAMPRELL PRICE TARGET TO 154 (180) PENCE - 'OVERWEIGHT'
----------
PANMURE CUTS BORDERS & SOUTHERN PETROLEUM PRICE TARGET TO 40 (50) PENCE - 'BUY'
----------
PANMURE CUTS FAROE PETROLEUM PRICE TARGET TO 180 (200) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.